A Decision Aid for Women With Early Stage Breast Cancer
Development and Evaluation of Different Versions of the Decision Board for Early Breast Cancer
Sponsor: Ontario Clinical Oncology Group (OCOG)
Listed as NCT00201929, this PHASE3 trial focuses on Breast Cancer and remains completed. Sponsored by Ontario Clinical Oncology Group (OCOG), it has been updated 6 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Apr 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ontario Clinical Oncology Group (OCOG)
- Supportive Cancer Care Research Unit
- U.S. Army Medical Research and Development Command
For direct contact, visit the study record on ClinicalTrials.gov .